Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Amgen USD 32.75B 152M 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
Heron Therapeutics USD 1.41M 212K 2023-09
Intra Cellular Therapies USD 10K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
J&J USD 3.12B 0 2023-09
Marinus Pharmaceuticals USD 55K 4K 2023-09
Merck USD 1.79B 0 2023-09
Minerva Neurosciences USD 1000 0 2023-09
Nektar Therapeutics USD 19K 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
Otsuka Holdings JPY 81.69B 0 2023-09
Ovoca Bio EUR 11.06M 0 2022-06
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Revance Therapeutics USD 88K 0 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



ALKERMES Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.